Corrigendum to 'TAZ is Indispensable for C-Myc-induced Hepatocarcinogenesis' [J Hepatol (2022) 123-134].

Haichuan Wang,Shanshan Zhang,Yi Zhang,Jiaoyuan Jia,Jingxiao Wang,Xianqiong Liu,Jie Zhang,Xinhua Song,Silvia Ribback,Antonio Cigliano,Matthias Evert,Bingyong Liang,Hong Wu,Diego F Calvisi,Yong Zeng,Xin Chen

DOI: https://doi.org/10.1016/j.jhep.2021.12.006

IF: 25.7

2021-01-01

Journal of Hepatology

Abstract:It has come to our attention that we inadvertently used the same western blot images for c-MYC and GAPDH in Fig. 1A of this article and in Fig. 1C of another paper by our group (Wang et al., Cell Death Dis. 2021; 12(2): 200). To avoid any confusion and future problems we have re-run the western blots for Fig. 1A of this paper. The new Fig. 1A is included below. We apologise for any inconvenience caused. TAZ is indispensable for c-MYC-induced hepatocarcinogenesisJournal of HepatologyVol. 76Issue 1PreviewMounting evidence implicates the Hippo downstream effectors Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) in hepatocellular carcinoma (HCC). We investigated the functional contribution of YAP and/or TAZ to c-MYC-induced liver tumor development. Full-Text PDF